|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/28 | |
| A61K 38/26 | |||
| A61P 3/10 | |||
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 9/00 |
| (11) | Number of the document | 3417871 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18165437.7 |
| Date of filing the European patent application | 2010-11-11 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 102009052831 | 2009-11-13 | DE | |
| 102010020902 | 2010-05-18 | DE |
| (72) |
Hagendorf, Annika, DE
Hauck, Gerrit, DE
Müller, Werner, DE
Schoettle, Isabell, DE
Siefke-Henzler, Verena, DE
Tertsch, Katrin, DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt,
DE
|
| (54) | PHARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND EINEN GLP-1-AGONISTEN, EIN INSULIN UND METHIONIN |
| PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST, AN INSULIN, AND METHIONINE |